HANSA BIOPHARMA AB SK 1 earnings per share and revenue

24H earnings per share for the last quarter are -0.36 EUR whereas the estimation was -0.30 EUR which accounts for -19.94% surprise. Företagets omsättning för samma period uppgår till 4.85 M EUR trots den uppskattade siffran 4.68 M EUR. Estimated earnings per share for the next quarter are -0.24 EUR, and revenue is expected to reach 4.70 M EUR. Also watch annual changes over time to get a bigger picture of 24H earnings per share and revenue dynamics.